Early growth patterns and long-term obesity risk

Nicolas Stettler1, Violeta Iotova

  • 1The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. nstettle@upenn.edu

Insights

Early growth patterns are linked to later obesity, offering hope for new prevention strategies. Research confirms this association, but more evidence is needed to establish causality for public health recommendations.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Obesity is a growing global health concern with complex origins.
  • Early life factors, including fetal development and infancy growth, are increasingly recognized as critical determinants of long-term health.
  • Understanding these early life influences is crucial for developing effective obesity prevention strategies.

Purpose of the Study:

  • To provide an updated review of recent scientific findings on the association between early growth patterns and the development of obesity.
  • To explore potential mechanisms and related outcomes linking early life exposures to later obesity.
  • To inform the development of novel, early-intervention strategies for obesity prevention.

Main Methods:

  • Systematic review of recent observational and intervention studies.
  • Analysis of data on fetal growth, gestational weight gain, maternal diabetes, and infancy weight gain in relation to obesity.
  • Synthesis of findings on causality and safety of early growth interventions.

Main Results:

  • Recent research continues to confirm the association between early growth patterns (fetal, infancy) and the risk of childhood and adulthood obesity.
  • Factors such as fetal growth, gestational weight gain, maternal diabetes, and infancy weight gain are consistently linked to later obesity.
  • While observational studies are abundant, emerging intervention studies provide mixed support for observed associations, highlighting the need for further research.

Conclusions:

  • Existing evidence strongly supports a link between early growth patterns and subsequent obesity development.
  • Establishing causality and ensuring the safety of interventions targeting early growth are critical next steps.
  • Translating these findings into effective public health recommendations requires robust evidence on causality and safety.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...